2026 Summit Program
BOSTON INTERNATIONAL BIOTECHNOLOGY SUMMIT
Friday 23 OCT. 2026
All Day (All Times Below are US ET)
CIC CAMBRIDGE One Broadway, 5th Floor, MA 02142
[Note: ID needed to access building]:
- 5th Floor: HAVANA [Main Room] + New Santo Domingo
- International Live Streaming Technology.
- Capacity in-Person ~150 attendees
- Santo Domingo Room Functions: Catering – Networking – Sponsors
PROGRAM GOVERNANCE:
- International Program and Steering Committee [Please refer to About Us/ International Program Committee]
- Honorary President: Professor V MILLER, Executive Director, Forum for Collaborative Research, Washington DC. & University of Berkeley, CA.
Nota Bene: Finalization of the Program content of the 9th Boston Paris Biotechnology Summit™ is ongoing under the supervision of the <International Steering Committee> listed under the “Program Committee” tab of the website. While every effort is being made to finalize the content and speakers, the Organizers maintain an option to modify the content and update the timings. We invite you to consult the website and social media postings and apologize for any inconvenience caused by such changes.
SUMMIT MISSION:
An exclusive, Trans-Atlantic bridge designed to foster innovative synergies between biotech and pharma companies, healthcare-focused cities, and regional clusters, institutional, philanthropic and strategic investors. The Summit’s intent is to spark projects, their financings and strategic deals to solve unmet medical needs to improve patient lives globally.
@ 9:00 AM: OPENING SEQUENCE
HAPPY 10th ANNIVERSARY! Video celebrating 10 Years: https/tinyurl.com/2yjj8vzh
<Meeting Unmet Informational Needs for the Biotechnology Community>
Boston Biotechnology Summit Co-founders: Soheila and Shahin Gharakhanian, MD
- Jeanne LECLAIR, Chief Business Officer, MASSACHUSETTS LIFE SCIENCES CENTER
- Jeevan RAMAPRIYA, MBA, Executive Director, MASSACHUSETTS OFFICE of TRADE & INVESTMENT(MOITI)
2026 Summit Core Theme:
Collaboration
CORE 10th Anniversary 2026 THEMATIC: COLLABORATION:
In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) offers a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality relative to a mutually exclusive and collectively exhaustive list of diseases and injuries. The need for such a global collaborative approach came to us from observing the formidable challenge of responding to the global burden of disease(s) (reference: *GBD 2019 Diseases and Injuries Collaborators* Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1135–59). No region or organization can handle such or business, Public Health or scientific needs alone.
@ 9:30 AM: OPENING KEYNOTE <MASTER CLASS>
Professor Veronica MILLER, Executive Director of the Forum for Collaborative Research (Washington DC), and Adjunct Professor at the University of California, Berkeley School of Public Health.
Lessons from the Forum for Collaborative Research: 1997-2026.
Veronica Miller, PhD, will share her experience of the forum, a collaboration between industry, regulatory agencies, patients, and public health/clinical researchers designed to advance regulatory science and accelerate drug development in areas of unmet medical need.
@ 10:30 AM PANEL SESSION(S): FACETS OF COLLABORATION
Moderator(s) from Program Committee:
- Leslie COUSSENS, PhD, GI Search & Evaluation Lead, R&D Business Development Center for External Innovation, TAKEDA Pharmaceuticals.
- Shahin GHARAKHANIAN, MD, DPH, Summit Co-Founder & Program Lead, specialized in Drug & Vaccine Clinical Development & Medical Affairs.
Panel Speakers:
- Peter RAY, MBA, Vice-President, NOVARTIS [Boston Campus].
Perspectives on Decision Making during Collaborations: As VP, Head of Portfolio Analytics at Novartis AG, Peter Ray leads the team responsible for strategic portfolio analytics, prioritization frameworks, and project/asset valuations covering 60+ assets and 120+ clinical projects.
- Jerome WINDSOR, PharmD, CBO & Senior Vice-President, AITIA (AI)
- Representative from SERVIER Pharmaceuticals.
CASE STUDY: SERVIER Pharmaceuticals & AITIA collaboration for applied Artificial Intelligence. Application of AI to develop In-silico models of human disease biology that informs drug discovery d development.
- Jan DE BACKER, MSc, Chief Science and Innovation Officer & General Manager North America, BANOOK Group, Atlanta GA
Collaboration to Generate Advanced Precision Biomarkers
- Collaborative approaches in biomedical imaging by combination of imaging modalities, advanced engineering methods such as like Finite Element Analysis (FEA) a computerized method used to predict how an engineering product reacts to real-world forces and Machine Learning.
- David Sharrow, Partner, Head of Life Sciences Licensing Group at Orrick, Boston.
Legal Optimization of your Deal Terms
@ 11:15 AM: MASTER WORKSHOP 1:
Clinical Trials: 2026 Tendencies & Trends, State-of-the-Art
Moderator from Program Committee:
Vanessa EL HARRAR, MD, Vice President & Global Medical Officer, Vaccines & Government Services (PPD) THERMOFISHER Scientific Group.
WORKSHOP CODUCTED BY the THERMOFISHER SCIENTIIFIC GROUP
- Ariel Berger, MPH, is an Executive Director, Integrated Solutions, U.S. Database Analytics with PPD™ Evidera™ Real-World Data & Scientific Solutions (RWD&SS) at Thermo Fisher Scientific. Mr. Berger has experience across a wide range of therapeutic areas, including but not limited to pulmonary arterial hypertension, infectious diseases, oncology, cardiovascular disease, osteoarthritis, neuropathic pain, fibromyalgia, migraine headache, mental health disorders, end-stage renal disease, and ostomy/incontinence care
- Sarah Edrie is Executive Director, Applied AI within the Clinical Research Group at Thermo Fisher Scientific, where she focuses on translating emerging AI capabilities into secure, compliant, and scalable solutions for clinical research.
- Joël Schaerer, PhD is Senior Director of Imaging AI at Clario, where he leads initiatives at the intersection of medical imaging, artificial intelligence, and clinical research.
@ 12 PM: LUNCH & NETWORKING
@ 1 PM:
1 – COLLABORATION with BIOTECHNOLOGY INDUSTRY EXPERT SERVICES:
- JAB Law PLLC Presentation by Jed GORDON, Head of IP
2 – SPECIAL SESSION: INTERNATIONAL PERSPECTIVES IN BIOTECHNNOLOGY
Snapshots of Biotechnology & Life Sciences from Business, Resources & Science Perspectives.
Moderator(s) from Program Committee:
- Rachele RYAN, MA, Senior Director, Partnering & Programs, LabCentral, Cambridge MA.
REPRESENTATIVES (alphabetically ordered):
CANADA: Cory Olishansky, Consul and Senior Trade Commissioner at Consulate General of Canada in Boston
FRANCE: Jerome Revole, Director Healthcare and Life Sciences, Business France North America
JAPAN: Namika Maki, Head of Japan Desk, CIC Japan Desk
3 – SPECIAL ANNOUNCEMENT:
Launch ANNOUNCEMENT: GLSG: Global Life Science Gateway, Cambridge MA, USA.
- Sunhee Hong, PhD; Jung “John” Hoon Woo, PhD, Managing Partners.
@ 2 PM: SUMMIT MASTER WORKSHOP 2:
Artificial Intelligence applied to Pharmaceutical R&D, State-of-the-Art.
Moderator(s) from Program Committee:
- Mikael PETROSYAN, PhD (MIT), Strategic Initiatives Lead, Global Medical, TAKEDA Pharmaceuticals. Vice-President, Society for Decision Professionals, Boston Chapter.
Workshop conducted by Professor Samuel Scarpino, PhD, the Executive Director, and the Director of AI + Life Sciences at the Institute for Experiential AI at Northeastern University and a Professor of the Practice in Health and Computer Sciences.
A research institute advancing Responsible AI solutions, solving high-impact challenges, and pioneering experiential AI education. Experiential AI is simply AI with a human-in-the-loop. Samuel Scarpino also holds appointments in the Khoury College of Computer Sciences, the Network Science Institute, the Barnett Institute for Chemical and Biological Analysis, and the Roux Institute.
@ 3:00 PM: SUMMIT SIGNATURE EVENT:
Feedback Report(s) By CEO(s) who pitched in past Summit(s):
- Frank BORRIELLO, CEO ALLOPLEX Biotherapeutics, Boston MA.
<INTERNATIONAL PITCH COMPETITION>
List of 10 Pitch Companies will be added progressively
ArtBlood | Eun Jug Baek |
Cell Knit | Jungho Lee |
Cellweaverse | Gun Sik Cho |
Ethic Stem | Hun Lee |
IeumBio | Yumi Kim |
Jericho Sciences | Heidi Kay |
Plaspeau | Hari Kim |
Shape BioPharmaceuticals | Arin Ghasparian |
Versatope | Christopher Locher |
Moderator(s) from Program Committee:
Silvia HELOU, MD, Principal, HC Consulting, Expert in Clinical Development & Operation,
Program Committee Member in charge of Mentoring. Greater New York Area.
PITCH JURY MEMBERS – BOSTON MA BASED: Alphabetically ordered
Sonalee BARTHAKUR, MA, Associate Director, External Innovation, Servier Pharmaceuticals, Boston MA.
[CHAIR] Leslie COUSSENS, PhD, GI Search & Evaluation Lead, R&D Business Development Center for External Innovation, TAKEDA Pharmaceuticals.
Eric EVANS, BS (Physics), Executive Committee of M2A: Mass Medical Angels; Senior Fellow, Harvard Kennedy School, Boston MA
Jeff Goldberg, BS (Cornell) S.M (MIT), Representing Launchpad Ventures, LLC, Boston MA.
Anthony Renodon, Associate Director BD, Flagship Pioneering, Boston MA.
Rachele RYAN, MA, Senior Director, Partnering & Programs, LabCentral, Cambridge MA.
Marie-Astrid SEVILLA, Pharm D, Representing Springboard Health Angels (Berlin, Germany) & Chief of Staff at Tissium (Paris FR & Cambridge MA).
Kamran TAVANGAR, PhD, MBA, AB, Head of Science and Partnerships at the Biotech Launchpad, LabCentral, Cambridge MA.
Short Pitch by Victoire Bedeaux representing Horiana
Company Presentations Outside Competition:
| ABLE Labs | Sang Shin |
| Delight Food | Hong Sup Hwang |
| Edgene | Paul Youngho Kim |
| EXOSYSTEMS Inc. | Hooman Lee |
| Gbrain | Byung Kwan Kim Sunggu Yang |
| K-MV | Myung Chul Lee |
| Omniamed | Won Jung Kim |
| Two-N | Jaehun Kim |
Register Today
Ready to register for the Boston Biotechnology Summit? Click the button below to get started with your registration process.
